X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs AJANTA PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE AJANTA PHARMA CADILA HEALTHCARE/
AJANTA PHARMA
 
P/E (TTM) x 32.4 24.6 131.7% View Chart
P/BV x 6.0 10.1 59.4% View Chart
Dividend Yield % 0.8 0.6 132.1%  

Financials

 CADILA HEALTHCARE   AJANTA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
AJANTA PHARMA
Mar-16
CADILA HEALTHCARE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4601,720 26.7%   
Low Rs3051,103 27.7%   
Sales per share (Unadj.) Rs92.1194.6 47.3%  
Earnings per share (Unadj.) Rs14.845.2 32.8%  
Cash flow per share (Unadj.) Rs18.550.3 36.7%  
Dividends per share (Unadj.) Rs3.208.00 40.0%  
Dividend yield (eoy) %0.80.6 147.6%  
Book value per share (Unadj.) Rs68.0132.0 51.5%  
Shares outstanding (eoy) m1,023.7488.77 1,153.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.27.3 57.3%   
Avg P/E ratio x25.831.2 82.7%  
P/CF ratio (eoy) x20.728.1 73.8%  
Price / Book Value ratio x5.610.7 52.6%  
Dividend payout %21.617.7 122.1%   
Avg Mkt Cap Rs m391,581125,299 312.5%   
No. of employees `00016.9NA-   
Total wages/salary Rs m15,0022,570 583.8%   
Avg. sales/employee Rs Th5,594.5NM-  
Avg. wages/employee Rs Th890.1NM-  
Avg. net profit/employee Rs Th899.9NM-  
INCOME DATA
Net Sales Rs m94,29517,275 545.8%  
Other income Rs m1,286166 773.3%   
Total revenues Rs m95,58117,442 548.0%   
Gross profit Rs m19,0365,807 327.8%  
Depreciation Rs m3,750451 832.2%   
Interest Rs m45049 920.2%   
Profit before tax Rs m16,1225,474 294.5%   
Minority Interest Rs m3380-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,2891,460 88.3%   
Profit after tax Rs m15,1684,014 377.9%  
Gross profit margin %20.233.6 60.1%  
Effective tax rate %8.026.7 30.0%   
Net profit margin %16.123.2 69.2%  
BALANCE SHEET DATA
Current assets Rs m60,2237,639 788.4%   
Current liabilities Rs m53,0582,715 1,954.5%   
Net working cap to sales %7.628.5 26.7%  
Current ratio x1.12.8 40.3%  
Inventory Days Days7043 161.5%  
Debtors Days Days8879 112.1%  
Net fixed assets Rs m72,9846,914 1,055.6%   
Share capital Rs m1,024177 578.9%   
"Free" reserves Rs m68,57611,442 599.4%   
Net worth Rs m69,60011,721 593.8%   
Long term debt Rs m24,684149 16,599.9%   
Total assets Rs m152,20714,814 1,027.4%  
Interest coverage x36.8112.9 32.6%   
Debt to equity ratio x0.40 2,795.4%  
Sales to assets ratio x0.61.2 53.1%   
Return on assets %10.327.4 37.4%  
Return on equity %21.834.2 63.6%  
Return on capital %17.946.5 38.5%  
Exports to sales %055.1 0.0%   
Imports to sales %06.0 0.0%   
Exports (fob) Rs mNA9,527 0.0%   
Imports (cif) Rs mNA1,038 0.0%   
Fx inflow Rs m21,28010,422 204.2%   
Fx outflow Rs m10,8741,678 648.0%   
Net fx Rs m10,4068,744 119.0%   
CASH FLOW
From Operations Rs m13,4953,264 413.5%  
From Investments Rs m-29,103-2,093 1,390.6%  
From Financial Activity Rs m23,158-1,186 -1,953.1%  
Net Cashflow Rs m7,556-15 -51,054.1%  

Share Holding

Indian Promoters % 74.8 73.8 101.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 1.6 535.5%  
FIIs % 5.9 7.6 77.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.0 64.7%  
Shareholders   44,069 20,968 210.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  SUVEN LIFE  ALEMBIC PHARMA  WOCKHARDT LTD.  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Metal Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading marginally above the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Feb 21, 2018 03:01 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS